2012
DOI: 10.1093/schbul/sbs136
|View full text |Cite
|
Sign up to set email alerts
|

Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis

Abstract: Background: The current diagnostic system for subjects at enhanced clinical risk of psychosis allows concurrent comorbid diagnoses of anxiety and depressive disorders. Their impact on the presenting high-risk psychopathology, functioning, and transition outcomes has not been widely researched. Methods: In a large sample of subjects with an At-Risk Mental State (ARMS, n = 509), we estimated the prevalence of DSM/SCID anxiety or depressive disorders and their impact on psychopathology, functioning, and psychosis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

45
504
9
2

Year Published

2014
2014
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 512 publications
(560 citation statements)
references
References 46 publications
45
504
9
2
Order By: Relevance
“…This finding may tentatively suggest a greater relevance of affective pathways rather than pathways via threat anticipation in the prodromal period of psychosis when a considerable proportion experience comorbid anxiety and depression. 51 We did not find evidence in support of our hypotheses that aberrant salience mediated the effects of threat anticipation and negative affect on PE. What is more, event-related stress was associated with a slight decrease in aberrant salience, which, in turn, was associated with less intense PE in FEP individuals, who all (but one) received prior or ongoing treatment with antipsychotic medication.…”
Section: Comparison With Previous Researchcontrasting
confidence: 79%
“…This finding may tentatively suggest a greater relevance of affective pathways rather than pathways via threat anticipation in the prodromal period of psychosis when a considerable proportion experience comorbid anxiety and depression. 51 We did not find evidence in support of our hypotheses that aberrant salience mediated the effects of threat anticipation and negative affect on PE. What is more, event-related stress was associated with a slight decrease in aberrant salience, which, in turn, was associated with less intense PE in FEP individuals, who all (but one) received prior or ongoing treatment with antipsychotic medication.…”
Section: Comparison With Previous Researchcontrasting
confidence: 79%
“…A review estimated that at least 50% of patients suffer from comorbid depression (Buckley et al, 2009), and many patients show single depressive symptoms such as low self-esteem (Freeman et al, 1998;Kesting and Lincoln, 2013;Moritz et al, 2010). Second, suicidality, a grave and life-threatening manifestation of depression, is frequent in psychosis and approximately 5% of patients commit suicide (Hor and Taylor, 2010).While some suicides are due to the influence of acoustic hallucinations, depression represents the best predictor for suicidality or selfharm behaviors in patients with schizophrenia (Fusar-Poli et al, 2014). Third, the implicit prevailing treatment paradigmposits that improving positive symptoms and insight will raise quality of life and reduce depression.…”
Section: Reasons Why Depression Is An Important Treatment Target In Smentioning
confidence: 99%
“…Research suggests, however, that enhancement of insight can even paradoxically aggravate affective problems (Karow et al, 2008;Lincoln et al, 2007). Moreover, depression is not just a secondary consequence of having a severe mental disorder, it is also a frequent premorbid precursor of psychosis (Fusar-Poli et al, 2014). Fourth, depressive symptoms are often formulated by patients as their preferred target of treatment (Byrne et al, 2010;Hafner et al, 2013;Sterk et al, 2013;Moritz et al, in press-b).…”
Section: Reasons Why Depression Is An Important Treatment Target In Smentioning
confidence: 99%
“…A recent meta-analysis in 1683 UHR subjects confirmed that baseline prevalence of co-morbid depressive and anxiety disorders is 41 % and 15 % respectively (P. Fusar-Poli et al, 2012b), with comorbidity rates varying greatly between studies (depression: 95% CI 32.5%-49.4%; anxiety: 95% CI 8.9%-25%; (P. Fusar-Poli et al, 2012b)). It is thus surprising that the rate of comorbid depression and/or anxiety in our sample was relatively low (26%).…”
Section: Discussionmentioning
confidence: 95%